Product
Sintilimab+Pegaspargase
1 clinical trial
2 indications
Indication
Natural Killer/T-Cell LymphomaIndication
Nasal and Nasal-TypeClinical trial
A Multicenter, Randomized, Controlled Phase II Screening Study of Combined Sequential Chemotherapy and Radiation Therapies for Early-stage Natural Killer/T-cell Lymphoma (IE/IIE)Status: Recruiting, Estimated PCD: 2026-12-30